DOX-DNA Interactions on the Nanoscale: In Situ Studies Using Tip-Enhanced Raman Scattering

ORCID
0000-0001-9803-883X
Affiliation
Department of Chemical Physics, Faculty of Chemistry ,Jagiellonian University ,Gronostajowa 2 ,30-387 Krakow ,Poland
Majzner, Katarzyna;
GND
118202634
Affiliation
Friedrich Schiller University Jena, Institute of Physical Chemistry and Abbe Center of Photonics ,Helmholtzweg 4 ,Jena 07743 ,Germany
Deckert-Gaudig, Tanja;
ORCID
0000-0001-8826-3144
Affiliation
Department of Chemical Physics, Faculty of Chemistry ,Jagiellonian University ,Gronostajowa 2 ,30-387 Krakow ,Poland
Baranska, Malgorzata;
GND
172837197
ORCID
0000-0002-0173-7974
Affiliation
Friedrich Schiller University Jena, Institute of Physical Chemistry and Abbe Center of Photonics ,Helmholtzweg 4 ,Jena 07743 ,Germany
Deckert, Volker

Chemotherapeutic anthracyclines, like doxorubicin (DOX), are drugs endowed with cytostatic activity and are widely used in antitumor therapy. Their molecular mechanism of action involves the formation of a stable anthracycline-DNA complex, which prevents cell division and results in cell death. It is known that elevated DOX concentrations induce DNA chain loops and overlaps. Here, for the first time, tip-enhanced Raman scattering was used to identify and localize intercalated DOX in isolated double-stranded calf thymus DNA, and the correlated near-field spectroscopic and morphologic experiments locate the DOX molecules in the DNA and provide further information regarding specific DOX-nucleobase interactions. Thus, the study provides a tool specifically for identifying intercalation markers and generally analyzing drug–DNA interactions. The structure of such complexes down to the molecular level provides mechanistic information about cytotoxicity and the development of potential anticancer drugs.

Preview

Cite

Citation style:
Could not load citation form.

Rights

License Holder: © 2024 The Authors. Published by American Chemical Society

Use and reproduction: